Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SBRT vs TACE as Bridge to Transplant in HCC
NCT02182687Phase 2Completed
- Sponsor
- Lahey Hospital & Medical Center
- Start
- Jun 2014
- Primary completion
- Oct 2021
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hepatocellular carcinoma (HCC) (2 arms), sponsored by Lahey Hospital & Medical Center. Primary endpoint: Freedom From Progression Over Time at 12 months. Started Jun 2014; status: completed.
02
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02182687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02182687.